loader from loading.io

The End of Alzheimer's? The heralded arrival of prevention and reversal with Dale Bredesen MD

Evolving Past Alzheimer's

Release Date: 11/01/2017

Methylene Blue & It’s Potential in Alzheimer’s  show art Methylene Blue & It’s Potential in Alzheimer’s

Evolving Past Alzheimer's

Part 2 of the conversation with Francisco Gonzalez-Lima. We are talking about Methylene Blue as a potential therapy for Alzheimer’s. This is something that you can access yourself with the proper research needed to obtain a pharmaceutical grade. We talk about its potential as a therapy for early intervention and prevention of Alzheimer’s.

info_outline
Brain Energetics & 2 New Potential Therapies in Alzheimer's  show art Brain Energetics & 2 New Potential Therapies in Alzheimer's

Evolving Past Alzheimer's

This is a super technical episode. The guest is a world leader in brain energy and its impact on cognition and cognitive change that leads to Alzheimer’s. We had to break this episode into two parts.

info_outline
The End of Alzheimer’s with Dr. Dale Bredesen  show art The End of Alzheimer’s with Dr. Dale Bredesen

Evolving Past Alzheimer's

Dr. Dale Bredesen is a neuroscientist of the first order as well as a truly pioneering doctor in the fields of Alzheimer’s and Parkinson’s research.

info_outline
BrainSee - Early Detection of Alzheimer's show art BrainSee - Early Detection of Alzheimer's

Evolving Past Alzheimer's

The field of preventive neurology is coming.  Detection of early brain damage is critical and our guest this episode, Darmiyan appears to have developed this technology. A highly technical, but potentially game-changing episode.

info_outline
Cognitive Benefits of Crossfit...Yes even for Cognitive Benefits of Crossfit...Yes even for "older" brains and bodies!

Evolving Past Alzheimer's

In Feb 2018 Michele Mootz started the CrossFit Wellness Program focused on bringing CrossFit to populations that were not being addressed including those with serious chronic diseases as well as aging adults over 65 including those with cognitive impairment.  We discuss the tremendous benefits they have seen to date. We also discuss the impact COVID has had on this program and the overall health of this community of individuals.

info_outline
More on COVID-19 & the Brain show art More on COVID-19 & the Brain

Evolving Past Alzheimer's

In this episode we talk with neurologist Suzanne Gazda MD. Dr Gazda is an authority on neurodegenerative diseases and offers more insight to balancing the "mental" vs "physical" risks in the age of coronavirus and social distancing. We focus on inflammation, auto-immune disease, Alzheimer's, and isolation.   

info_outline
NeuroCOVID & Alzheimer's. What You Can Do To Protect Yourself show art NeuroCOVID & Alzheimer's. What You Can Do To Protect Yourself

Evolving Past Alzheimer's

This is a review of the neurological symptoms that are associated with COVID-19.  We discuss the implications of COVID-19 on Alzheimer's disease and other dementias.  We discuss what you can do to protect yourself.  

info_outline
Telomerase Therapy for Alzheimer's? show art Telomerase Therapy for Alzheimer's?

Evolving Past Alzheimer's

Dr Michael Fossel received his MD and his PhD from Stanford University. He has published numerous articles in both high impact medical journals and popular press.  His book The Telomerase Revolution was hailed by the WSJ as one of the five best science books of 2015.  

info_outline
Light Therapy for Alzheimer's - Part 2 transcranial photobiomodulation show art Light Therapy for Alzheimer's - Part 2 transcranial photobiomodulation

Evolving Past Alzheimer's

This is the second part of a rich discussion between Anita Saltmarche and Dr Nate Bergman.  It features transcranial photobiomodulation (PBM), or shining LED light energy into the brain.  Anita has led numerous clinical trials and has over 17 years of experience with this technology. A good discussion about which devices, how much to use, and more information about the VieLight product

info_outline
Light Therapy for Alzheimer's - Part 1 transcranial photobiomodulation show art Light Therapy for Alzheimer's - Part 1 transcranial photobiomodulation

Evolving Past Alzheimer's

This is the first part of a rich discussion between Anita Saltmarche and Dr Nate Bergman.  It features, transcranial-photobiomodulation (PMB), or shining LED or low level laser light energy into the brain known. We talk about near-infrared and red light, the important wavelengths and intensities of over the counter and prescriber only devices. We specifically look at the research around the VieLight product. 

info_outline
 
More Episodes
Dr Dale Bredesen is an internationally recognized researcher in Alzheimer's.  His incredible resume includes being the Director of the Easton Center for Alzheimer's Research at UCLA as well as founding president and CEO of the Buck Institute on Aging in Novato, California.  He has worked in the lab of 2 nobel prize winners and has run his own labs for 28 years looking at neurodegenerative diseases - focusing on Alzheimer's.
 
Dr Bredesen's fundamental theory is that Alzheimer's is actually a protective brain response to different classes of insults.
 

Classes of Insults Leading to Alzheimer’s

  1. Inflammation and the brain’s response to pathogens/infections – these trigger the creation of amyloid beta, a key chemical in the brain that destroys brain cell connections and is believed to be a key factor in the development of Alzheimer’s. Amyloid Beta is a part of the Innate Immune system which seems to be over stimulated or dysregulated in most cases of Alzheimer’s. Dr. Bredesen explains the connection of immune activation in Alzheimer’s.
  2. Inadequate amounts OR withdrawal of support of brain-“growing” chemicals like B12, vitamin D, and other hormones. This results in a downsizing of the networks of brain cell connections.
  3. Sugar toxicity – damages via:
    1. advanced glycation end products (AGEs) acting to damage through inflammation as well as,
    2. loss of cell supports because of shoddy insulin signaling necessary for healthy brain activity.
  4. A protective response by amyloid that bind to things that the brain perceives as a toxin – things like: copper, iron, mercury, biotoxins, infections.
  5. People in their 50s and early 60s tend to have the more “toxic” form.
  6. Problems with blood vessels and leakiness in the protective blood-brain-barrier which result in lower support chemicals and toxicity.
  7. Trauma, e.g., from things like concussions – which also lower chemical and hormone support as well as make the brain susceptible to all the insults mentioned above.

The story of “Patient Zero” (Minute 28:53)
Dr. Bredesen describes the first success he had with his program.

Things that induce Alzheimer’s a.k.a. “Dementogens”

  • Biotoxins
    • Exposures to water building and the harmful effects of mold
    • Tick exposures
  • Heavy Metals Exposure
    • Aluminum, copper, mercury
  • Water damaged building, mycotoxins
  • Certain types of infections
  • Concussions
  • The effects of diabetes and poor diet
  • Certain types of pollution
  • Not enough time asleep or insufficient oxygen when you sleep.\
  • Not enough exercise

Elements of a “Cognoscopy”
Because the brain changes in Alzheimer’s can creep in 20 years or more before symptoms start prevention makes a whole lot of sense. Though a cognoscopy doesn’t really exist yet in a conventional medical setting, Dr. Bredesen’s thinks that one should probably be done around age 45 to assess the risk of developing Alzheimer’s and might include the following:

  1. Genetic markers and blood work that elucidates Dr. Bredesen’s three metabolic subtypes (see an MPICognitions.com to find a doctor trained in the protocol).
  2. Functional cognitive testing using BrainHQ, Lumosity, Cog-state, CNS vital signs to see where your brain function is in a “testing environment”.
  3. Brain MRI with volumetrics (listen to Evolving Past Alzheimer’s podcast with Dr. Cyrus Raji episode #6 for full explanation) if someone has symptoms.

The Role of Sleep in Alzheimer’s

  • Time of repair (don’t eat 3 hours before bed)
  • Time for autophagy (brain cell “pruning”)
  • There is a slight change in the microanatomy of the brain where some of the accumulated toxicants get “washed away”
  • Sleep hygiene is important


Who typically improves with the Bredesen Program?
Dr. Bredesen mentions the “MoCA” which refers to the Montreal Cognitive Assessment. This is a screening test that won’t tell you if someone has Alzheimer’s but can give you a general indication of different levels of cognitive impairment.  Dr. Bredesen mentioned that people that score 22 or greater (out of 30) are seeing improvements with his methodology.  These are people that are typically early on in their disease.

Who typically does not improve with the Bredesen Program?

  • People that are more “frail” (less able to exercise, etc.)
  • People that are further along with the disease and have had symptoms for longer periods of time.


How much improvement do people see with the Bredesen Program?
Some people seem to get just a bit better in terms of mood, outlook, and brain function. Others get much better and almost completely back to their best brain function. Too early to say how many, but more than half of the people using the methodology report some sort of improvement.

A discussion of an upcoming Documentary of the impact on people’s lives using Dr. Bredesen’s program.

 
Resources